Galmed Pharmaceuticals Ltd.
GLMD
$1.07
$0.1111.59%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/1/2025
-
PR Newswire
11/28/2025
-
Ticker Report
11/27/2025
-
Ticker Report
11/26/2025
-
TipRanks Financial Blog
11/26/2025
-
GuruFocus
11/26/2025
-
PR Newswire
11/18/2025
-
TipRanks Financial Blog
11/18/2025
-
PR Newswire
11/18/2025
-
Ticker Report
11/18/2025
-
Stocktwits News Feed
11/17/2025
-
Globe Newswire
11/17/2025
-
PR Newswire
11/9/2025
-
Ticker Report
10/3/2025
-
Ticker Report
9/10/2025
-
Ticker Report
8/28/2025
-
GuruFocus
8/28/2025
-
GuruFocus
8/28/2025
-
PR Newswire
8/25/2025
-
TipRanks Financial Blog
8/25/2025
-
PR Newswire
6/23/2025
-
Ticker Report
5/27/2025
-
PR Newswire
5/23/2025
-
Ticker Report
5/23/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 26, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Beginning of April (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 3 693 8448
Address
16 Abba Hillel Road
Ramat Gan, 5250608
Ramat Gan, 5250608
Country
Year Founded
Business Description
Sector
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty...
more